# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-24-127626
Filing Date
2024-12-11
Accepted
2024-12-11 16:25:34
Documents
37
Period of Report
2024-12-11
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | tm2430782d1_8k.htm iXBRL | 8-K | 26295
2 | EXHIBIT 99.1 | tm2430782d1_ex99-1.htm | EX-99.1 | 20200
6 | GRAPHIC | tm2430782d1_ex99-1img001.jpg | GRAPHIC | 97098
7 | GRAPHIC | tm2430782d1_ex99-1img002.jpg | GRAPHIC | 195792
8 | GRAPHIC | tm2430782d1_ex99-1img003.jpg | GRAPHIC | 98551
9 | GRAPHIC | tm2430782d1_ex99-1img004.jpg | GRAPHIC | 197595
10 | GRAPHIC | tm2430782d1_ex99-1img005.jpg | GRAPHIC | 70412
11 | GRAPHIC | tm2430782d1_ex99-1img006.jpg | GRAPHIC | 89225
12 | GRAPHIC | tm2430782d1_ex99-1img007.jpg | GRAPHIC | 113403
13 | GRAPHIC | tm2430782d1_ex99-1img008.jpg | GRAPHIC | 115888
14 | GRAPHIC | tm2430782d1_ex99-1img009.jpg | GRAPHIC | 98783
15 | GRAPHIC | tm2430782d1_ex99-1img010.jpg | GRAPHIC | 102043
16 | GRAPHIC | tm2430782d1_ex99-1img011.jpg | GRAPHIC | 155977
17 | GRAPHIC | tm2430782d1_ex99-1img012.jpg | GRAPHIC | 81629
18 | GRAPHIC | tm2430782d1_ex99-1img013.jpg | GRAPHIC | 146819
19 | GRAPHIC | tm2430782d1_ex99-1img014.jpg | GRAPHIC | 110102
20 | GRAPHIC | tm2430782d1_ex99-1img015.jpg | GRAPHIC | 113776
21 | GRAPHIC | tm2430782d1_ex99-1img016.jpg | GRAPHIC | 70217
22 | GRAPHIC | tm2430782d1_ex99-1img017.jpg | GRAPHIC | 90646
23 | GRAPHIC | tm2430782d1_ex99-1img018.jpg | GRAPHIC | 76152
24 | GRAPHIC | tm2430782d1_ex99-1img019.jpg | GRAPHIC | 125789
25 | GRAPHIC | tm2430782d1_ex99-1img020.jpg | GRAPHIC | 125402
26 | GRAPHIC | tm2430782d1_ex99-1img021.jpg | GRAPHIC | 117782
27 | GRAPHIC | tm2430782d1_ex99-1img023.jpg | GRAPHIC | 356837
28 | GRAPHIC | tm2430782d1_ex99-1img024.jpg | GRAPHIC | 82928
| Complete submission text file | 0001104659-24-127626.txt |  | 4133387

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA | anvs-20241211.xsd | EX-101.SCH | 3021
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | anvs-20241211_lab.xml | EX-101.LAB | 34240
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | anvs-20241211_pre.xml | EX-101.PRE | 22363
39 | EXTRACTED XBRL INSTANCE DOCUMENT | tm2430782d1_8k_htm.xml | XML | 3791

Mailing Address 101 LINDENWOOD DRIVE, SUITE 225 MALVERN PA 19355
Business Address 101 LINDENWOOD DRIVE, SUITE 225 MALVERN PA 19355 484-875-3192
Annovis Bio, Inc. (Filer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39202 | Film No.: 241541826
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)